A synthetic peptide for use as a blocking control in assays to test for specificity of NOG antibody, Alternative Names: Noggin control peptide, Noggin antibody Blocking Peptide, Anti-Noggin Blocking Peptide, SYM1 Blocking Peptide, SYNS1 Blocking Peptide, NOG Blocking Peptide, SYM1 Blocking Peptide, Symphalangism 1 (proximal) Blocking Peptide, Synostoses (multiple) syndrome 1 Blocking Peptide, SYNS 1 Blocking Peptide
Aufreinigung
The antibody is affinity-purified from rabbit antiserum by affinity chromatography using epitope-specific immunogen.
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
NOG
(Noggin (NOG))
Synonyme
SYM1 Peptide, SYNS1 Peptide, nog-A Peptide, nog1 Peptide, noggin-1 Peptide, noggin Peptide, noggin Peptide, noggin L homeolog Peptide, noggin protein Peptide, NOG Peptide, Nog Peptide, nog.L Peptide, noggin Peptide
Hintergrund
The secreted polypeptide, encoded by this gene, binds and inactivates members of the transforming growth factor-beta (TGF-beta) superfamily signaling proteins, such as bone morphogenetic protein-4 (BMP4). By diffusing through extracellular matrices more efficiently than members of the TGF-beta superfamily, this protein may have a principal role in creating morphogenic gradients.